Pharmacokinetic Evaluation of Rofecoxib: Comparison of Tablet and Suspension Formulations

By Schwartz J.I.  

Clinical Drug Investigation, Vol. 23, Iss. 8, 2003-01 ,pp. : 503-509

Adis International

Access to resources Recommend Favorite

Eslicarbazepine Acetate (BIA 2-093): Relative Bioavailability and Bioequivalence of 50 mg/mL Oral Suspension and 200mg and 800mg Tablet Formulations

By Fontes-Ribeiro Carlos  

Drugs in R&D, Vol. 6, Iss. 5, 2005-01 ,pp. : 253-260

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and comparative bioavailability of domperidone suspension and tablet formulations in healthy adult subjects

By  

Clinical Pharmacology In Drug Development, Vol. 3, Iss. 2, 2014-03 ,pp. : 126-131

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pilot Study of Relative Bioavailability of Two Oral Formulations of Ketoprofen 25 mg in Healthy Subjects. A Fast-Dissolving Lyophilized Tablet as Compared to Immediate Release Tablet

By Ahmed I. S.   Fatahalla F. A.  

Drug Development and Industrial Pharmacy, Vol. 33, Iss. 5, 2007-05 ,pp. : 505-511

Informa Healthcare

Access to resources Recommend Favorite

Bioequivalence study with lapatinib powder for oral suspension and the original tablet formulation in cancer patients

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 3, 2015-03 ,pp. : 203-209

John Wiley & Sons Inc

Access to resources Recommend Favorite